• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Evaxion Biotech A/S ADR (NQ: EVAX )

    2.760 -0.040 (-1.43%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 13,765
    Open 2.900
    Bid (Size) 2.650 (1)
    Ask (Size) 3.090 (10)
    Prev. Close 2.800
    Today's Range 2.640 - 2.930
    52wk Range 2.260 - 13.82
    Shares Outstanding 37,897,780
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    iAccess Alpha's Buyside Best Ideas Virtual Summer Conference June 25-26, 2024
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga

    Performance

    YTD
    -62.19%
    -62.19%
    1 Month
    -2.82%
    -2.82%
    3 Month
    -34.13%
    -34.13%
    6 Month
    -24.61%
    -24.61%
    1 Year
    -78.10%
    -78.10%

    More News

    Read More
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Recap: Evaxion Biotech Q4 Earnings
    Via Benzinga
    EVAX Stock Earnings: Evaxion Biotech Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Evaxion Announces Business Update and First Quarter 2024 Financial Results
    From Evaxion Biotech
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
    From Evaxion Biotech
    Via GlobeNewswire
    EVAX Stock Earnings: Evaxion Biotech Meets EPS for Q4 2023
    Via InvestorPlace
    Evaxion Announces Business Update and Full Year 2023 Financial Results
    From Evaxion Biotech
    Via GlobeNewswire
    Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
    From Evaxion Biotech
    Via GlobeNewswire
    Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations
    From Evaxion Biotech
    Via GlobeNewswire
    Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
    From Evaxion Biotech
    Via GlobeNewswire
    Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement
    From Evaxion Biotech
    Via GlobeNewswire
    Evaxion Announces Closing of $15 Million Public Offering
    From Evaxion Biotech
    Via GlobeNewswire
    Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Evaxion Biotech Announces Pricing of $15 Million Public Offering
    From Evaxion Biotech
    Via GlobeNewswire
    Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Dow Edges Lower; US Composite PMI Rises In January
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Cancer Therapy Focused Evaxion Biotech Stock Trading Higher Today?
    Via Benzinga
    Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.